Comparable stake leader
UBS Group AG
SEC ownership of BioNexus Gene Lab Corp
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001737523.
Disclosed value leader
UBS Group AG
Comparable rows
0/4
Latest evidence
31 Mar 2026
- Public ticker
- BGLC on Nasdaq
- Parsed ownership sources
-
13F and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
UBS Group AG
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
31 Mar 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001737523
- Issuer location
- Kuala Lumpur
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of BioNexus Gene Lab Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
UBS Group AG
Disclosed value leader
UBS Group AG
Comparable rows
0/4
Latest evidence
31 Mar 2026
13F
3/4/5
Highest disclosed value: $495
4 rows are not safely comparable across share classes.
Quick read
UBS Group AG has the largest disclosed position value at $495.
0 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens UBS Group AG's linked filing trail.
Disclosed position value
Top 2
UBS Group AG
$495
WELLS FARGO & COMPANY/MN
$2
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-4 of 4 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| UBS Group AG |
13F
Company
|
—
class O/S missing
|
$495
231 shares
|
— | 31 Mar 2026 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
—
class O/S missing
|
$2
1 shares
|
— | 31 Mar 2026 |
| Tai Tan Liong |
3/4/5
Chief Operating Officer, Director
|
—
class O/S missing
|
—
12,500,460 shares
|
— | 19 Jul 2023 |
| Wei Li Leong |
3/4/5
Chief Financial Officer
|
—
class O/S missing
|
—
4,797,709 shares
|
— | 19 Jul 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 21 Jul 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-10 of 10 reporting-owner rows connected to BioNexus Gene Lab Corp. Open a relationship link for the CIK-to-CIK filing trail.
Rows
10
Largest Forms 3/4/5 holder
Chak Hua Yew
Net 12M change
$0
Latest report
19 Jul 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Chak Hua Yew | Director | Mixed | 19 Jul 2023 | |||
| Tai Tan Liong | Chief Operating Officer, Director | Mixed | 19 Jul 2023 | |||
| Wei Li Leong | Chief Financial Officer | Mixed | 19 Jul 2023 | |||
| Boon Teong Teoh | Director | Mixed | 19 Jul 2023 | |||
| Chai Ping Lin | Director | Mixed | 19 Jul 2023 | |||
| Teng Fook Fong | Director | Mixed | 19 Jul 2023 | |||
| Sook Keng Yeoh | Chief Executive Officer, Director | Mixed | 19 Jul 2023 | |||
| Yeat Min Fong | Director | Mixed | 19 Jul 2023 | |||
| Chee Keong Yap | Director | Mixed | 19 Jul 2023 | |||
| Yee Meng Wong | President, Director | Mixed | 19 Jul 2023 |
Recent insider transactions for BioNexus Gene Lab Corp
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.